期刊文献+

网络药理学:中医药与转化医学研究新途径 被引量:8

Network pharmacology:a new approach to translational medical research and traditional Chinese medicine
下载PDF
导出
摘要 方剂与证候是中医药的重要特色和中心内容。目前,理解中药方剂与病证的生物学基础是中医药现代研究的一个重点,亟需新的研究方法和途径。随着系统生物学等交叉学科的兴起,以生物分子网络为切入点的网络药理学和网络医学有望系统地刻画中医药的整体性特征,从一个新的视角阐释中医证候的生物学基础和中药方剂的药效物质基础。本文将简要介绍中医药与转化医学的研究现状、生物分子网络在该研究领域中的作用及其应用前景。 The formulae and ZHENG/syndromes are the key features of traditional Chinese medicine (TCM). Cur-rently, new methods and approaches are urgently needed to understand the biological basis of Chinese herbal formulae and ZHENG/syndromes in translational medical research on Chinese medicine. With the launch of system biology, network med-icine and network pharmacology based on bio-molecular networks are expected to systematically describe the hohstic character- istics of Chinese medicine, explain the biological basis of ZHENG/syndromes in Chinese medicine and interpret the material basis for the efficacy of traditional Chinese medicine prescriptions from a new perspective. This article will briefly discuss the current state of translational medical research in Chinese medicine, the roles of bio-molecular networks in this research and its prospects for the future application.
出处 《转化医学研究(电子版)》 2013年第3期1-11,共11页 Translational Medicine Research(Electronic Edition)
基金 国家自然科学基金(No.81303139 81225025 60934004)资助~~
关键词 网络药理学 生物分子网络 中医药 转化医学 network pharmacology, bio-molecular network, traditional Chinese medicine, translational medicine
  • 相关文献

参考文献4

二级参考文献17

共引文献471

同被引文献156

  • 1陈佳韵,陈艳.浅谈对抗病毒类中药的研究[J].求医问药(下半月),2013(6):171-172. 被引量:1
  • 2张伯礼,王永炎.方剂关键科学问题的基础研究——以组分配伍研制现代中药[J].中国天然药物,2005,3(5):258-261. 被引量:159
  • 3王阶,郭丽丽,杨戈,王永炎.方剂配伍理论研究方法及研究前景[J].世界科学技术-中医药现代化,2006,8(1):1-5. 被引量:36
  • 4中国科学院.昆明动物所在动物中药成分研究方面取得新成果[J].成果与项目,2003,28(6):794.
  • 5吴潇湘.我国丹参酮类生物合成研究获重大突破[N].中国中医药报,2013-8-2,第一版.
  • 6潘锋.中药安全性关键技术研究取得突破[N].中国科学报,2014-01-23,第4版.
  • 7Gao R. et al. Human infection with a novel avian - origin influenza A (HTN9) virus. New England Journal of Medi- cine, 2013, 368(20) :1888 - 1897.
  • 8Uyeki TM, Cox NJ. Global concerns regarding novel influ- enza A (H7N9) virus infections. New England Journal of Medicine, 2013, 368(20) :1862 - 1864.
  • 9Hansen E, Day T, Arino J. et al. Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks. Ca- nadian journal of infectious diseases and medical microbiol- ogy, 2010, 21(1) :28 -63.
  • 10Hu Y. et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding amt emergence of antiviral re- sistaJme. Lancet. 2013,381 (9885) :2273 - 2279.

引证文献8

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部